CIMdata PLM Industry Summary Online Archive

10 March 2005

Company News

Agile to Present at Pharma-Biotech PLM Summit

Agile Software Corporation announced its participation in the first annual Pharma-Biotech Product Lifecycle Management Strategies Executive Summit. Pharmaceutical and biotechnology executives from around the world will gather for this summit in San Diego on May 23-24, 2005 to hear from leading industry experts on the role that PLM is having in improving operating profitability, research and development cycles, and time-to-market execution in these highly competitive industries.

Mike Jansen, director, pharmaceutical industry business consulting at Agile Software, will present an executive brief titled "How PLM Can Improve Product Profitability Even Before You Launch" on Monday, May 23. Other leading industry experts presenting at the summit include:

•  John Dikran Balian, MD, vice president and worldwide head of project planning and performance in development operations, Pfizer, Inc. (Opening Keynote)

•  Emily S. Winn-Deen, Ph.D., vice president, strategic planning and business development, Cepheid

•  Hans Hoogkamer, director of science and business affairs, Actelion Pharmaceuticals ltd. Switzerland

•  Miriam Halperin-Wernli, vice president, head of science and business affairs, Actelion Pharmaceuticals ltd. Switzerland

•  David Silver, senior vice president, strategic marketing, aaiPharma Inc

•  Robert Gallotto, vice president, commercial development and alliance management, Altus Pharmaceuticals. Inc.

•  Bobba Venkatadri, senior vice president, operations, Aradigm Corporation

•  Alan Lewis, president, Signal Research Division, Celgene Corporation

•  Peter M. Clarke, Ph.D., vice president, production and technical processes, Introgen Therapeutics, Inc.

•  Joseph Koziak, executive vice president, Isotechnika, Inc.

•  Susan Jane Herbert, corporate vice president, head of reproductive health and metabolic endocrinology global product development, Serono

•  David Gillen MD, senior medical director, Pfizer, Inc.

•  Susan J. Ward, Ward Consulting

"PLM strategy is becoming an important component of the business and drug development process. Some companies have already seen the benefits of PLM while others haven't even begun to think about it," said Raida Hicks, summit organizer and president, RH Production Consultancy. "Maintaining the profitability of a drug and getting to market at the right time are the competitive issues that mean success or failure for today's drug developers; and PLM is a proven solution that will help them achieve these key objectives."

"Many of today's drug developers have a 'reactive' product development process that decreases the likelihood for commercial market success," said Mike Jansen, Agile. "This summit will demonstrate to senior biotech and pharmaceutical executives how PLM can help their companies take a 'strategic' approach to product development that increases competitiveness and top-line returns."

The Pharma-Biotech PLM Management Strategies Executive Summit was created with the help of a senior advisory board of more than 15 industry experts who shaped the agenda to address the most critical issues for today's drug developers. More information on the summit can be found online at http://www.rhproductionconsultancy.com/events/052005.html .

 

Become a member of the CIMdata PLM Community to receive your daily PLM news and much more.

Tell us what you think of the CIMdata Newsletter. Send your feedback.

CIMdata is committed to your privacy. Your personal information will never be sold or shared outside of CIMdata without your express permission.

Subscribe